Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Soluble CD40L, risk of recurrent cardiac events and atorvastatin in the MIRACL Study

Soluble CD40L, risk of recurrent cardiac events and atorvastatin in the MIRACL Study. 2003.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.